Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » Sysmex Obtains Japan Marketing Approval for Use of Saliva With Coronavirus Kit

Sysmex Obtains Japan Marketing Approval for Use of Saliva With Coronavirus Kit

Jun 10, 2020
|
staff reporter

NEW YORK ─ Sysmex said Tuesday it has obtained marketing approval in Japan for the use of saliva with BGI Genomics' 2019-nCoV Fluorescence Detection Real-Time RT-PCR Kit.

In March, Kobe, Japan-based Sysmex had obtained marketing approval in the country for the distribution of the kit to detect the RNA of SARS-CoV-2 extracted from upper respiratory tract swabs or lower respiratory tract sputum or bronchoalveolar lavage fluids.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Cost of Meeting Cancellations

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

Genetic Nondiscrimination Act Upheld

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

Enhancement Avoidance

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

PLOS Papers on Shigella Insertion Sequences, Antigens and Plasmodium vivax Diversity, More

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
22
Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Sponsored by
Thermo Fisher Scientific

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

Sponsored by
Roche

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Aug
25
Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Sponsored by
Roche

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

  2. SARS-CoV-2 Pandemic May Promote Progress in Paper MDx

    Premium

  3. Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark

  4. Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer

  5. Study Sees Survival Boost For BRCA1/2 Carriers Tested Before Breast Cancer Diagnosis

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.